Skip to content

Improving executive functioning in patients with Mild Cognitive Impairment by transcranial alternate current brain stimulation

Improving executive functioning in patients with Mild Cognitive Impairment by transcranial alternate current brain stimulation - Cognitive function in MCI after tACS

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON48713
Enrollment
90
Registered
2018-08-30
Start date
2018-11-08
Completion date
Unknown
Last updated
2024-09-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

cognitive impairment dementia MCI nervous system

Interventions

None listed

Sponsors

Universitair Medisch Centrum Groningen
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: Diagnosis of aMCI based on neurologists evaluation. Age >=50 years aMCI will be defined as having a verbal memory score 1.5 standard deviations below the normative control values on both sub-scales. Signed written informed consent.

Exclusion criteria

Exclusion criteria: 1. History of psychiatric or neurological illness other than MCI 2. Metal implants (e.g., pacemaker, heart valves, vascular clips, eye-implants, copper containing intra-uterine devices, non-removable piercing, cerebral implants) 3. Any risk of having metal particles in the eyes 4. Tattoos containing iron oxide (often found in red pigments) 5. Claustrophobia 6. Alcohol or drug abuse 7. Excessive intake alcohol (>2 units per day); 8. Recent use of alcohol (2 days before the EEG and/or fMRI measurement). 9. Refusal to be informed of structural brain abnormalities that could be detected using MRI during the experiment 10. Severe scalp skin lesions 11. Color blindness

Design outcomes

Primary

MeasureTime frame
After two-weeks stimulation: - Change in fronto-temporal synchronization (measured by resting state EEG). - Change in working memory measured with the off-line n-back task and WAIS-WM. - Decreased reaction time (VRRT).

Secondary

MeasureTime frame
- Improvement in daily activities (IADL), functional connectivity (fMRI) during task and rest, general executive functioning and memory performance after two weeks of stimulation. - Duration of effects (up to one year). - Correlation of salivary levels of lactoferrin with change in EEG synchronization and cognitive performance

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)